Evaluation and diagnosis of multiple sclerosis in adults FDA approves new drug to treat multiple sclerosis
Network of Pediatric MS Centers FDA approves new oral drug to treat multiple sclerosis

Pathogenesis and epidemiology of multiple sclerosis.

كل ما تريد معرفته عن التصلّب اللويحي
: Churchill Livingstone Elsevier; 2013
موقع الإماراتية
ما هو مرض التصلب اللويحي .. أسبابه وأعراضه وعلاجه » مجلتك
Clinical presentation, course, and prognosis of multiple sclerosis in adults
Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination In: Bradley's Neurology in Clinical Practice
Treatment of acute exacerbations of multiple sclerosis in adults Therapeutic decision making in a new drug era in multiple sclerosis

Siponimod versus placebo in secondary progressive multiple sclerosis EXPAND : A double-blind, randomised, phase 3 study.

ما هو التصلب اللويحي
Multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system
موقع الإماراتية
Multiple sclerosis in 2018: New therapies and biomarkers
التصلب اللويحي وأعراضه وعلاجه
Novel immunomodulatory approaches for the management of multiple sclerosis